Dropletbiosci

2 known investors

Droplet has developed a platform to collect and profile patient lymph fluid from routine surgical drain fluid, enabling a lymph-based liquid biopsy. It aims to support earlier, more precise post-surgical cancer care and build a lymph dataset for insights into patient selection and treatment response.